Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy
Condition(s):IgA NephropathyLast Updated:February 10, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):IgA NephropathyLast Updated:February 10, 2022Terminated
Condition(s):Neoplasm, Ovarian; Fallopian Tube Cancer; Primary Peritoneal Cavity Cancer; Adenocarcinoma Ovary; Serous Adenocarcinoma of Ovary; Serous Adenocarcinoma of Primary Peritoneum; Primary Peritoneal Carcinoma; High Grade Serous AdenocarcinomaLast Updated:March 21, 2024Active, not recruiting
Condition(s):Primary Invasive Malignant Neoplasm of Female Breast; Carcinoma Breast; Breast Cancer Female; Carcinoma, Ductal, Breast; Stage II Breast Cancer; Stage I Breast Cancer; Stage III Breast CancerLast Updated:June 11, 2021Completed
Condition(s):Breast CancerLast Updated:March 22, 2017Completed
Condition(s):Healthy VolunteerLast Updated:August 9, 2018Completed
Condition(s):Recurrent High Grade Uterine CancerLast Updated:January 17, 2024Not yet recruiting
Condition(s):Urothelial CarcinomaLast Updated:February 14, 2024Active, not recruiting
Condition(s):Ovarian CancerLast Updated:February 13, 2023Completed
Condition(s):AVB – Atrioventricular Block; Fetal AVBLast Updated:July 19, 2023Recruiting
Condition(s):Frontotemporal Dementia; FTD; FTD-GRN; Dementia, FrontotemporalLast Updated:March 1, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.